Board Meeting7 Aug 2026, 12:40 pm
ANG Lifesciences Board Meeting on Aug 14 to Approve Q1 FY27 Results
AI Summary
ANG Lifesciences India Ltd has announced a Board of Directors meeting scheduled for August 14, 2026. The primary agenda is to consider and approve the standalone and consolidated un-audited financial results for the quarter ended June 30, 2026. The company has also informed that the trading window for its securities will remain closed from July 1, 2026, until 48 hours after the results are made public.
Key Highlights
- Board meeting scheduled for August 14, 2026.
- To approve standalone and consolidated financial results.
- Results are for the quarter ended June 30, 2026.
- Trading window closed from July 1, 2026.
Price Impact
More from ANG